OCREVUS contains the active ingredient ocrelizumab, a recombinant humanized monoclonal antibody targeting CD20-expressing B-cells. It is formulated as an injection for intravenous infusion, with each mL containing 30 mg of ocrelizumab. The solution includes inactive ingredients such as glacial acetic acid, polysorbate 20, sodium acetate trihydrate, and trehalose dihydrate. OCREVUS is supplied as a preservative-free, sterile solution in single-dose vials.

How should I use this medication?

This medicine is for injection into a vein. It is given by your care team in a hospital or clinic setting. A special MedGuide will be given to you before each treatment. Be sure to read this information carefully each time. Talk to your care team about the use of this medication in children. Special care may be needed.

Overdosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once. NOTE: This medicine is only for you. Do not share this medicine with others.

What if I miss a dose?

Keep appointments for follow-up doses. It is important not to miss your dose. Call your care team if you are unable to keep an appointment.

Where should I keep my medication?

This medication is given in a hospital or clinic. It will not be stored at home.

NOTE: This sheet is a summary. It may not cover all possible information. If you have questions about this medicine, talk to your doctor, pharmacist, or health care provider.

What side effects may I notice from receiving this medication?

Side effects that you should report to your care team as soon as possible: -Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat -Breast tissue changes, new lumps, redness, pain, or discharge from the nipple -Dizziness, loss of balance or coordination, confusion or trouble speaking -Infection—fever, chills, cough, sore throat, wounds that don't heal, pain or trouble when passing urine, general feeling of discomfort or being unwell -Infusion reactions—chest pain, shortness of breath or trouble breathing, feeling faint or lightheaded -Liver injury—right upper belly pain, loss of appetite, nausea, light-colored stool, dark yellow or brown urine, yellowing skin or eyes, unusual weakness or fatigue -Sudden or severe stomach pain, bloody diarrhea, fever, nausea, vomiting Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome): -Back pain -Diarrhea -Swelling of the ankles, hands, or feet -Worsening mood, feelings of depression

This list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What should I tell my care team before I take this medication?

They need to know if you have any of these conditions: -Cancer -Hepatitis B infection -Infection especially a viral infection, such as chickenpox, cold sores, herpes -An unusual or allergic reaction to ocrelizumab, other medications, foods, dyes or preservatives -Pregnant or trying to get pregnant -Breast-feeding

What may interact with this medication?

-Alemtuzumab -Anifrolumab -Belimumab -Natalizumab -Rituximab -Vaccines

This list may not describe all possible interactions. Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.

What should I watch for while using this medication?

Your condition will be monitored carefully while you are receiving this medication. This medication can cause serious allergic reactions. To reduce the risk, your care team may give you other medications to take before receiving this one. Be sure to follow the directions from your care team. Talk to your care team if you wish to become pregnant or think you might be pregnant. This medication can cause serious birth defects. Effective contraception is recommended during and for 6 months after stopping treatment. This medication may increase your risk of getting an infection. Call your care team for advice if you get a fever, chills, sore throat, or other symptoms of a cold or flu. Do not treat yourself. Try to avoid being around people who are sick. If you have hepatitis B, talk to your care team if you plan to stop this medication. The symptoms of hepatitis B may get worse if you stop this medication. In some patients, this medication may cause a serious brain infection that may cause death. If you have any problems seeing, thinking, speaking, walking, or standing, tell your care team right away. If you cannot reach your care team, urgently seek other source of medical care. This medication can decrease the response to a vaccine. If you need to get vaccinated, tell your care team if you have received this medication. Extra booster doses may be needed. Talk to your care team to see if a different vaccination schedule is needed. Talk to your care team about your risk of cancer. You may be more at risk for certain types of cancer if you take this medication.